Caligan Partners LP Diversified Active

CIK: 0001727492 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 13, 2024

Total Value ($000): $378,314 (100.0% shares, 0.0% debt)

Holdings (12)

LQDA LIQUIDIA CORPORATION 40.4%

Value ($000) $152,824 Shares 10,360,945 Est. Cost $5.57 Unrealized +149.6%

— ALIMERA SCIENCES INC 17.4%

Value ($000) $65,657 Shares 16,835,154 Est. Cost $3.09 Unrealized —

ANIK ANIKA THERAPEUTICS INC 9.6%

Value ($000) $36,474 Shares 1,435,993 Est. Cost $25.57 Unrealized -5.4%

EOLS EVOLUS INC 7.0%

Value ($000) $26,444 Shares 1,888,881 Est. Cost $9.41 Unrealized +38.0%

EXEL EXELIXIS INC 6.9%

Value ($000) $26,120 Shares 1,100,730 Est. Cost $18.35 Unrealized +21.1%

— VERONA PHARMA PLC 5.5%

Value ($000) $20,860 Shares 1,296,447 Est. Cost $17.51 Unrealized —

ENTA ENANTA PHARMACEUTICALS INC 4.0%

Value ($000) $14,982 Shares 858,070 Est. Cost $13.23 Unrealized 0.0%

AGIO AGIOS PHARMACEUTICALS INC 3.7%

Value ($000) $14,173 Shares 484,711 Est. Cost $22.85 Unrealized +17.2%

— Y-MABS THERAPEUTICS INC 2.5%

Value ($000) $9,549 Shares 587,276 Est. Cost $6.79 Unrealized —

OTLK OUTLOOK THERAPEUTICS INC 1.6%

Value ($000) $5,970 Shares 500,000 Est. Cost $8.09 Unrealized 0.0%

BCRX BIOCRYST PHARMACEUTICALS INC 1.0%

Value ($000) $3,853 Shares 758,502 Est. Cost $5.62 Unrealized 0.0%

NBP I MAB 0.4%

Value ($000) $1,407 Shares 756,538 Est. Cost $1.86 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
LQDA	LIQUIDIA CORPORATION	10,360,945	$152,824	40.4%	$5.57	+149.6%	COM NEW	53635D202
—	ALIMERA SCIENCES INC	16,835,154	$65,657	17.4%	$3.09	—	COM NEW	016259202
ANIK	ANIKA THERAPEUTICS INC	1,435,993	$36,474	9.6%	$25.57	-5.4%	COM	035255108
EOLS	EVOLUS INC	1,888,881	$26,444	7.0%	$9.41	+38.0%	COM	30052C107
EXEL	EXELIXIS INC	1,100,730	$26,120	6.9%	$18.35	+21.1%	COM	30161Q104
—	VERONA PHARMA PLC	1,296,447	$20,860	5.5%	$17.51	—	SPONSORED ADS	925050106
ENTA	ENANTA PHARMACEUTICALS INC	858,070	$14,982	4.0%	$13.23	0.0%	COM	29251M106
AGIO	AGIOS PHARMACEUTICALS INC	484,711	$14,173	3.7%	$22.85	+17.2%	COM	00847X104
—	Y-MABS THERAPEUTICS INC	587,276	$9,549	2.5%	$6.79	—	COM	984241109
OTLK	OUTLOOK THERAPEUTICS INC	500,000	$5,970	1.6%	$8.09	0.0%	COM	69012T305
BCRX	BIOCRYST PHARMACEUTICALS INC	758,502	$3,853	1.0%	$5.62	0.0%	COM	09058V103
NBP	I MAB	756,538	$1,407	0.4%	$1.86	—	SPONSORED ADS	44975P103